Skip to content

Life Sciences

Contamination Control Strategy

  • Life Sciences
  • 2 min read

In the past, contamination control was often managed in silos: HVAC handled ventilation, Architecture handled walls/ceilings/floors, and QA handled cleaning procedures. But under the updated EU GMP Annex 1, that approach is no longer sufficient.

A Contamination Control Strategy (CCS) is an integrated, end-to-end strategy that links all technical and organizational controls into one coherent system. Think of it as a mind map that makes the connection between facility design decisions and final product quality crystal clear. Without a CCS, your protective measures become scattered puzzle pieces—full of gaps and vulnerabilities.

How does Humiley Group INC develop and verify a CCS?

At Humiley, we don’t wait until the facility is built to “write a CCS.” We treat CCS as the project’s DNA, starting from the Concept phase:

1. Holistic approach check

We don’t design an AHU just to “meet cleanliness grades.” We design the AHU as an integral component of the CCS.

How we do it: We review the alignment between Hardware (design, equipment) and Software (operating procedures, cleaning and disinfection).

Example: If the cleaning procedure requires strong corrosive chemicals, the floor and wall materials in Humiley’s design must be selected to withstand those chemicals—not chosen purely for appearance.

2. Transfer points risk assessment

The highest cross-contamination risks are often at transfer points—where people and materials move.

Execution: We map all transfer points: personnel entry/exit, material in, waste out. At each point, we ask: What is the containment measure here? (Airlock? Passbox? Dynamic/Active or Passive?)

Verification: We apply FMEA (Failure Modes and Effects Analysis) to ensure no transfer point is left uncontrolled or unmitigated.

3. Annex 1 gap analysis

Before handover, Humiley performs a structured Gap Analysis against Annex 1 expectations.

Commitment: We cross-check the current design against every requirement across the 16 CCS elements listed in Annex 1 section 2.5. If we identify any “blank space” (e.g., missing continuous microbiological monitoring at a critical point), we immediately propose equipment additions or design modifications.

At Humiley Group INC, we don’t just deliver a facility—we deliver a robust, defensible contamination control strategy.

Industries

Related

More on this subject

WHO's 2022 sterile GMP and the barrier decision

WHO's 2022 GMP for sterile products (TRS 1044, Annex 2) follows EU Annex 1. For a WHO-prequalification plant the barrier comes first: a RABS needs a Grade B background, a closed isolator Grade D, and that sets the HVAC. The contamination control strategy should be written alongside the design.

InsightRead

A CCS nobody reviews is only a snapshot

Annex 1 expects the Contamination Control Strategy to be actively reviewed and updated. A yearly meeting catches changes late. Adding one question to every HVAC change control, EM adverse trend review and deviation closure form, asking whether the CCS still says the right thing, keeps it current with the site.

InsightRead

The revised EU GMP Annex 1 has applied since 25 August 2023, with point 8.123 following in 2024. A site still planning its gap assessment is years behind. Most findings land in the CCS, for example a pressure alarm delay set at commissioning that nobody can justify.

InsightRead